ISSN: 1859 - 2872
Characteristics of chest computed tomography images of patients with prolonged and post COVID-19 with lung lesions treated at the National Lung Hospital (in 92 cases), from January to March 2022
Main Article Content
Keywords
Abstract
Objective: To describe the characteristics of chest computed tomography (CT) images of patients in the prolonged period of COVID-19 and post-COVID-19 with lung damage, no history of underlying lung disease, who came to the clinic for examination and treated at the National Lung Hospital. Subject and method: 92 patients with a history of COVID-19 infection for more than 4 weeks, with negative rapid antigen or PCR test results for Sars-CoV-2; signs of respiratory infection, radiographs Chest X-ray showed lung abnormalities, chest computed tomography scan results and was hospitalized for treatment. Retrospective, descriptive, cross-sectional. Result and conclusion: Average age 53.3 ± 17.8 years; male/female was 51/41, persistent dry cough: 76.1%, feeling short of breath, short of breath: 58.7%; chest pain, discomfort in the chest: 41.3%, mild fever: 28.3%, high fever: 8.7%. The average time from COVID-19 infection to hospital admission: 68.5 days. Blood count: Average white blood cell count: 10.2G/L; neutral multinucleus: 79%, average CRP: 12.54mg/l. Chest CT image: GGO: 85.9%, czary paving: 17.4%, solidification: 62%, interstitial fibrosis (subpleural curve/bilateral peripheral reticular opacity): 19.7%, pulmonary varicose veins: 16.3%, bronchiectasis: 53.3%, pulmonary artery thrombosis in the central and subcenter: 12.0%, organization (condensation/halo reversal): 34.8%, hilar and mediastinal lymphadenopathy: 0%, pleural effusion: 1.1%, there were no cases with pericardial effusion, pulmonary lymphadenopathy, mediastinum and cavernous shape; Injury to two lungs: 83.7%. Chest CT has an important role in supporting the diagnosis of lung injury in patients in the prolonged period of COVID-19 and after COVID-19.
Article Details
References
2. Caruso D, Guido G, Zerunian M et al (2021) Post-Acute sequelae of COVID-19 pneumonia: Six-month Chest CT Follow-up. Radiology 301(2): 396-405. doi: 10.1148/radiol.2021210834.
3. Van den Borst B, Peters JB, Brink M et al (2021) Comprehensive health assessment 3 months after recovery from acute coronavirus disease 2019 (COVID-19). Clin Infect Dis 73(5): 1089-1098. doi: 10.1093/cid/ciaa1750.
4. Susanto AD, Triyoga PA, Isbaniah F et al (2021) Lung fibrosis sequelae after recovery from COVID-19 Infection. J Infect Dev Ctries 15(3): 360-365. doi: 10.3855/jidc.13686.
5. Stylemans D, Smet J, Hanon S et al (2021) Evolution of lung function and chest CT 6 months after COVID-19 pneumonia: Real-life data from a Belgian University Hospital. Respir Med 182: 106421. doi: 10.1016/j.rmed.2021.106421.
6. Webb RW and Higgins CB (2017) Thoracic Imaging: Pulmonary and Cardiovascular Radiology. Wolter Kluer; 3th edition: 2-39, 346-456.
7. Chen Q, Chen L, Liu S et al (2021) Three-dimensional ct for quantification of longitudinal lung and pneumonia variations in COVID-19 patients. Front Med (Lausanne) 8: 643917. doi: 10.3389/fmed.2021. 643917. eCollection 2021. PMID: 33842505.
8. Aydin S, Unver E, Karavas E et al (2021) Computed tomography at every step: Long coronavirus disease. Respir Investig 59(5): 622-627. doi: 10.1016/j.resinv. 2021.05.014.
9. Vijayakumar B, Tonkin J, Devaraj A et al (2021) CT Lung Abnormalities after COVID-19 at 3 Months and 1 Year after Hospital Discharge. Radiology. 5: 211746. doi: 10.1148/radiol.2021211746.
10. Rabiee B, Eibschutz LS, Asadollahi S et al (2021) The role of imaging techniques in understanding and evaluating the long-term pulmonary effects of COVID-19. Expert Rev Respir Med 15(12): 1525-1537. doi: 10.1080/17476348.2021.2001330.
11. Bellan M, Baricich A, Patrucco F et al (2021) Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. Sci Rep 11(1): 22666. doi: 10.1038/s41598-021-01215-4. PMID: 34811387.
12. Li X, Shen C, Wang L et al (2021) Pulmonary fibrosis and its related factors in discharged patients with new corona virus pneumonia: A cohort study. Respir Res. 22(1): 203. doi: 10.1186/s12931-021-01798-6.
Article Sidebar
